human cell stress array kit (R&D Systems)
Structured Review
![( A ) Wright-Giemsa staining of <t>cells</t> after 5-day treatment [Cis (0.45 μg/ml) and Dau (0.175 μg/ml)]. ( B ) Immunofluorescence staining of CD14 and the statistical data of the nucleus areas stained by DAPI. Scale bar, 20 μm. ( C ) Cathepsin B evaluation by a Magic Red assay <t>kit</t> and the relative integrated density of Magic Red in cytoplasm. Scale bar, 10 μm. ( D ) FACS analysis of the CD14 expression with or without NAC pretreatment ( n = 3). ( E ) Relative ROS in Kasumi-1 cells incubated with Cis + Dau and HA/Cis/Dau with or without NAC pretreatment ( n = 3). ( F ) Proteome profiler <t>array.</t> “*,” “#,” or “&” P < 0.05; “**,” “##,” or “&&” P < 0.01; *** P < 0.001; **** P < 0.0001. Con, control.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2094/pmc11952094/pmc11952094__sciadv.ado3923-f5.jpg)
Human Cell Stress Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cell+stress+array+kit/pmc11952094-260-2-7?v=R%26D+Systems
Average 93 stars, based on 16 article reviews
Images
1) Product Images from "A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis"
Article Title: A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis
Journal: Science Advances
doi: 10.1126/sciadv.ado3923
Figure Legend Snippet: ( A ) Wright-Giemsa staining of cells after 5-day treatment [Cis (0.45 μg/ml) and Dau (0.175 μg/ml)]. ( B ) Immunofluorescence staining of CD14 and the statistical data of the nucleus areas stained by DAPI. Scale bar, 20 μm. ( C ) Cathepsin B evaluation by a Magic Red assay kit and the relative integrated density of Magic Red in cytoplasm. Scale bar, 10 μm. ( D ) FACS analysis of the CD14 expression with or without NAC pretreatment ( n = 3). ( E ) Relative ROS in Kasumi-1 cells incubated with Cis + Dau and HA/Cis/Dau with or without NAC pretreatment ( n = 3). ( F ) Proteome profiler array. “*,” “#,” or “&” P < 0.05; “**,” “##,” or “&&” P < 0.01; *** P < 0.001; **** P < 0.0001. Con, control.
Techniques Used: Staining, Immunofluorescence, Expressing, Incubation, Control
![Phosphorylation <t>of</t> <t>receptor</t> tyrosine kinases (RTKs) and their downstream effectors in human follicle dermal papilla cells treated with a Silybum marianum extract (SME, 30 μg/mL, dissolved in dimethylsulfoxide [DMSO]) or DMSO for 1 h ( n = 2 donors, tests performed in duplicate for DMSO‐treated and SME‐treated cells from each donor). (a) EGFR and PDGFRβ, and (b) the downstream phosphokinases ERK1/2, GSK3α/β, Akt1/2/3, STAT5α and STAT5α/β. Data were obtained using the Human <t>Proteome</t> Profiler Phospho‐RTK and Phospho‐Kinase array kits, respectively. Each bar represents the mean ± SEM of SME/DMSO ratio.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3400/pmc11603400/pmc11603400__JOCD-23--g003.jpg)